Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.4B | 11.7B | 5.8B | 14.6B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.1B | 1.2B | 1.3B | 1.2B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 358M | 379M | 420M | 411M |
| Other income expense | -6M | 52M | 59M | 72M |
| Pretax income | 2.3B | 699M | 2.1B | 2.3B |
| Tax provision | 338M | 76M | 406M | 274M |
| Net income | 1.9B | 623M | 1.7B | 2.1B |
| Basic EPS | 1.0 | 0.3 | — | 1.0 |
| Diluted EPS | 1.0 | 0.3 | — | 1 |
| Basic average shares | 1.7B | 1.7B | — | 1.8B |
| Diluted average shares | 1.7B | 1.7B | — | 1.8B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.9B | 623M | 1.7B | 2.1B |
| Minority interests | -49M | -66M | -22M | -131M |
| Preferred stock dividends | 85M | 72M | 47M | 97M |